Gilead Sciences, Inc. (GILD) vs Novartis AG (NVS)
A side-by-side comparison of Gilead Sciences, Inc. and Novartis AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
GILD
Gilead Sciences, Inc.
$144.74HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
NVS
Novartis AG
$141.00HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — GILD vs NVS
growth of $100 · dividends reinvested · last 10yGILD +178.4% (+10.8%/yr)NVS +209.2% (+12.0%/yr)NVS compounded faster over this window
GILD NVS
GILD vs NVS: by the numbers
- •NVS is the larger company ($268.00B vs $179.47B market cap).
- •NVS is profitable (22.93% net margin) while GILD runs a net loss (-10.64%).
- •GILD grew revenue faster over the past five years (2.72% vs 1.53% CAGR).
- •NVS pays the higher dividend yield (3.38% vs 2.20%).
Metrics side by side
Valuation
| Metric | GILD | NVS |
|---|---|---|
| P/E ratio | N/A | 21.27 |
| Forward P/E | N/A | 16.02 |
| PEG ratio | N/A | 1.38 |
| P/S ratio | 5.89 | 4.82 |
| P/B ratio | 15.17 | 6.45 |
| EV / EBITDA | N/A | 13.85 |
| FCF yield | N/A | 5.90% |
Profitability
| Metric | GILD | NVS |
|---|---|---|
| Gross margin | 79.59% | 74.44% |
| Operating margin | 39.74% | 30.54% |
| Net margin | -10.64% | 22.93% |
| ROE | -27.39% | 30.71% |
| ROIC | -3.66% | 13.93% |
Dividends
| Metric | GILD | NVS |
|---|---|---|
| Dividend yield | 2.20% | 3.38% |
| Payout ratio | N/A | 71.50% |
Growth (annualized)
| Metric | GILD | NVS |
|---|---|---|
| Revenue CAGR (5Y) | 2.72% | 1.53% |
| EPS CAGR (5Y) | 133.83% | 15.42% |
| FCF CAGR (5Y) | N/A | 8.92% |
| Total return CAGR (5Y) | 20.77% | 16.96% |
Frequently asked
- Which has grown faster, GILD or NVS?
- Over the past five years, GILD grew revenue faster — GILD at a 2.72% CAGR versus NVS at 1.53%.
- Does GILD or NVS pay a bigger dividend?
- GILD yields 2.20% and NVS yields 3.38% based on trailing dividends and the latest price.
- Is GILD or NVS more profitable?
- NVS runs the higher net margin — GILD at -10.64% versus NVS at 22.93%.
- How have GILD and NVS total returns compared?
- Over the past 10 years, GILD delivered 10.26% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Novartis AG P/E ratioGilead Sciences dividend yieldNovartis AG dividend yieldGilead Sciences ROENovartis AG ROEGilead Sciences operating marginNovartis AG operating marginGilead Sciences revenue growthNovartis AG revenue growthGilead Sciences free cash flowNovartis AG free cash flow
Gilead Sciences & Novartis AG appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.